Cargando…
Vigabatrin-associated brain abnormalities on MRI in tuberous sclerosis complex patients with infantile spasms: are they preventable?
BACKGROUND: Vigabatrin (VGB) is currently the most widely prescribed first-line medication for individuals with infantile spasms (IS) and especially for those with tuberous sclerosis complex (TSC), with demonstrated efficacy. Meanwhile, its adverse events, such as vigabatrin-associated brain abnorma...
Autores principales: | Wan, Lin, He, Wen, Wang, Yang-Yang, Xu, Yong, Lu, Qian, Zhang, Meng-Na, Wang, Qiu-Hong, Dun, Shuo, Liu, Li-Ying, Shi, Xiu-Yu, Wang, Jing, Hu, Lin-Yan, Zhang, Bo, Yang, Guang, Zou, Li-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806385/ https://www.ncbi.nlm.nih.gov/pubmed/36601084 http://dx.doi.org/10.1177/17562864221138148 |
Ejemplares similares
-
Vigabatrin-Induced Encephalopathy in a 5.5-Month-Old Girl with Infantile Spasms due to Tuberous Sclerosis
por: Klinaki, Eleni, et al.
Publicado: (2019) -
Safety and Efficacy of Vigabatrin for the Treatment of Infantile Spasms
por: Faulkner, Michele A., et al.
Publicado: (2011) -
Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms
por: Lerner, Jason T, et al.
Publicado: (2010) -
Response to sequential treatment with prednisolone and vigabatrin in infantile spasms
por: Dzau, Winston, et al.
Publicado: (2022) -
Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study
por: Westall, Carol A., et al.
Publicado: (2014)